Radiotherapy Alone and in Combination with Surgery for Squamous Cell Carcinoma of the Mouth, Pharynx, and Larynx

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedTreatmentCompletedno age specifiedNCIRTOG-7303


I.  Compare the efficacy of radiotherapy alone with pre-operative radiotherapy 
for patients with head and neck cancer.

Entry Criteria

Disease Characteristics:

See General Eligibility Criteria

Patient Characteristics:

See General Eligibility Criteria

General Eligibility Criteria:

Squamous cell carcinoma or 
lymphoepithelioma of oral cavity, oropharynx, supraglottic pharynx, and 
hypopharynx.  T3 or T4 lesions with nodes of any N stages, except N3A stages, 
and fixed course nodes.  Include T2 lesions for hypopharyngeal tumor.

Expected Enrollment

Protocol closed 05/79.


Randomized study.
Arm I:  Radiotherapy.
Arm II:  Surgery plus Pre-operative Radiotherapy.
Arm III:  Surgery plus Post-operative Radiotherapy.

Published Results

Tupchong L, Scott CB, Blitzer PH, et al.: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20 (1): 21-8, 1991.[PUBMED Abstract]

Tupchong L, Scott C, Blitzer SC, et al.: Preoperative (PRE-OP) vs. postoperative (POST-OP) radiation therapy in head and neck squamous cell carcinoma: long term follow-up on Radiation Therapy Oncology Group (RTOG) study 73-03. [Abstract] Proceedings of the American Society of Clinical Oncology 6: A-498, 127, 1987.

Marcial VA, Gelber R, Kramer S, et al.: Does preoperative irradiation increase the rate of surgical complications in carcinoma of the head and neck? A Radiation Therapy Oncology Group Report. Cancer 49 (6): 1297-301, 1982.[PUBMED Abstract]

Snow JB Jr, Gelber RD, Kramer S, et al.: Randomized preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck: preliminary report. Laryngoscope 90 (6 Pt 1): 930-45, 1980.[PUBMED Abstract]

Trial Contact Information

Trial Lead Organizations

Radiation Therapy Oncology Group

James Cox, MD, Protocol chair
Ph: 713-563-2316; 800-392-1611

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.